WO2015070242A2 - At-home light-emitting diode and massage device for vaginal rejuvenation - Google Patents
At-home light-emitting diode and massage device for vaginal rejuvenation Download PDFInfo
- Publication number
- WO2015070242A2 WO2015070242A2 PCT/US2014/065069 US2014065069W WO2015070242A2 WO 2015070242 A2 WO2015070242 A2 WO 2015070242A2 US 2014065069 W US2014065069 W US 2014065069W WO 2015070242 A2 WO2015070242 A2 WO 2015070242A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- vibration
- light
- vaginal tissue
- tissue
- range
- Prior art date
Links
- 230000003716 rejuvenation Effects 0.000 title claims abstract description 32
- 210000001519 tissue Anatomy 0.000 claims abstract description 103
- 108010035532 Collagen Proteins 0.000 claims abstract description 51
- 102000008186 Collagen Human genes 0.000 claims abstract description 50
- 229920001436 collagen Polymers 0.000 claims abstract description 47
- 230000000694 effects Effects 0.000 claims abstract description 33
- 210000002950 fibroblast Anatomy 0.000 claims abstract description 16
- 230000017423 tissue regeneration Effects 0.000 claims abstract description 10
- 230000035755 proliferation Effects 0.000 claims abstract description 7
- 230000008439 repair process Effects 0.000 claims abstract description 7
- 230000007246 mechanism Effects 0.000 claims description 47
- 238000000034 method Methods 0.000 claims description 42
- 230000004044 response Effects 0.000 claims description 24
- 238000001816 cooling Methods 0.000 claims description 21
- 238000001228 spectrum Methods 0.000 claims description 16
- 210000003205 muscle Anatomy 0.000 claims description 13
- 230000015572 biosynthetic process Effects 0.000 claims description 12
- 230000006870 function Effects 0.000 claims description 11
- 210000001215 vagina Anatomy 0.000 claims description 11
- 230000001965 increasing effect Effects 0.000 claims description 9
- 238000003786 synthesis reaction Methods 0.000 claims description 8
- 230000002757 inflammatory effect Effects 0.000 claims description 7
- 230000033115 angiogenesis Effects 0.000 claims description 6
- 239000003963 antioxidant agent Substances 0.000 claims description 6
- 230000003078 antioxidant effect Effects 0.000 claims description 6
- 235000006708 antioxidants Nutrition 0.000 claims description 6
- 230000006907 apoptotic process Effects 0.000 claims description 6
- 230000030833 cell death Effects 0.000 claims description 6
- 230000005012 migration Effects 0.000 claims description 6
- 238000013508 migration Methods 0.000 claims description 6
- 210000003365 myofibril Anatomy 0.000 claims description 6
- 238000001126 phototherapy Methods 0.000 claims description 6
- 230000003247 decreasing effect Effects 0.000 claims description 5
- 230000001939 inductive effect Effects 0.000 claims description 5
- 239000000314 lubricant Substances 0.000 claims description 5
- 239000012530 fluid Substances 0.000 claims description 4
- MCSXGCZMEPXKIW-UHFFFAOYSA-N 3-hydroxy-4-[(4-methyl-2-nitrophenyl)diazenyl]-N-(3-nitrophenyl)naphthalene-2-carboxamide Chemical compound Cc1ccc(N=Nc2c(O)c(cc3ccccc23)C(=O)Nc2cccc(c2)[N+]([O-])=O)c(c1)[N+]([O-])=O MCSXGCZMEPXKIW-UHFFFAOYSA-N 0.000 claims description 3
- 230000007423 decrease Effects 0.000 claims description 2
- 238000001514 detection method Methods 0.000 claims description 2
- 238000005728 strengthening Methods 0.000 claims 2
- 230000003213 activating effect Effects 0.000 claims 1
- 230000030393 positive regulation of fibroblast proliferation Effects 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 238000004088 simulation Methods 0.000 claims 1
- 210000004877 mucosa Anatomy 0.000 abstract description 20
- 238000004925 denaturation Methods 0.000 abstract description 12
- 230000036425 denaturation Effects 0.000 abstract description 12
- 210000002808 connective tissue Anatomy 0.000 abstract description 10
- 239000011159 matrix material Substances 0.000 abstract description 4
- 230000036760 body temperature Effects 0.000 abstract description 3
- 230000003328 fibroblastic effect Effects 0.000 abstract 1
- 230000028327 secretion Effects 0.000 abstract 1
- 238000011282 treatment Methods 0.000 description 34
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 19
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 19
- 210000002744 extracellular matrix Anatomy 0.000 description 19
- 239000000835 fiber Substances 0.000 description 16
- 230000008569 process Effects 0.000 description 13
- 238000002844 melting Methods 0.000 description 11
- 230000008018 melting Effects 0.000 description 11
- 108090000623 proteins and genes Proteins 0.000 description 10
- 102000004169 proteins and genes Human genes 0.000 description 10
- 230000000007 visual effect Effects 0.000 description 10
- 238000007634 remodeling Methods 0.000 description 9
- 102000016942 Elastin Human genes 0.000 description 7
- 108010014258 Elastin Proteins 0.000 description 7
- 230000035606 childbirth Effects 0.000 description 7
- 238000013461 design Methods 0.000 description 7
- 229920002549 elastin Polymers 0.000 description 7
- 230000014509 gene expression Effects 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 7
- 230000003287 optical effect Effects 0.000 description 7
- 238000001429 visible spectrum Methods 0.000 description 7
- 230000035876 healing Effects 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 238000004659 sterilization and disinfection Methods 0.000 description 5
- 102000012422 Collagen Type I Human genes 0.000 description 4
- 108010022452 Collagen Type I Proteins 0.000 description 4
- 102000016387 Pancreatic elastase Human genes 0.000 description 4
- 108010067372 Pancreatic elastase Proteins 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 238000004590 computer program Methods 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 208000023610 Pelvic Floor disease Diseases 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 230000005540 biological transmission Effects 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 230000003176 fibrotic effect Effects 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- 230000035882 stress Effects 0.000 description 3
- 238000001356 surgical procedure Methods 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 230000003827 upregulation Effects 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 102100026802 72 kDa type IV collagenase Human genes 0.000 description 2
- 101710151806 72 kDa type IV collagenase Proteins 0.000 description 2
- 206010000060 Abdominal distension Diseases 0.000 description 2
- 208000034347 Faecal incontinence Diseases 0.000 description 2
- 102000003886 Glycoproteins Human genes 0.000 description 2
- 108090000288 Glycoproteins Proteins 0.000 description 2
- 206010021143 Hypoxia Diseases 0.000 description 2
- 206010021639 Incontinence Diseases 0.000 description 2
- 229920000106 Liquid crystal polymer Polymers 0.000 description 2
- 239000004977 Liquid-crystal polymers (LCPs) Substances 0.000 description 2
- 102000007000 Tenascin Human genes 0.000 description 2
- 108010008125 Tenascin Proteins 0.000 description 2
- 206010046543 Urinary incontinence Diseases 0.000 description 2
- 206010051873 Vaginal relaxation Diseases 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 230000000692 anti-sense effect Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 210000001612 chondrocyte Anatomy 0.000 description 2
- 230000037319 collagen production Effects 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 230000008602 contraction Effects 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000007954 hypoxia Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 230000033001 locomotion Effects 0.000 description 2
- 229920002529 medical grade silicone Polymers 0.000 description 2
- 230000003387 muscular Effects 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000036407 pain Effects 0.000 description 2
- 208000013823 pelvic organ prolapse Diseases 0.000 description 2
- 230000008447 perception Effects 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000002040 relaxant effect Effects 0.000 description 2
- 238000004153 renaturation Methods 0.000 description 2
- 230000003595 spectral effect Effects 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- 230000003313 weakening effect Effects 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- 108010085238 Actins Proteins 0.000 description 1
- 102000007469 Actins Human genes 0.000 description 1
- 101100239693 Dictyostelium discoideum myoD gene Proteins 0.000 description 1
- 102000016359 Fibronectins Human genes 0.000 description 1
- 108010067306 Fibronectins Proteins 0.000 description 1
- 206010017533 Fungal infection Diseases 0.000 description 1
- 229910052689 Holmium Inorganic materials 0.000 description 1
- 102100030412 Matrix metalloproteinase-9 Human genes 0.000 description 1
- 108010015302 Matrix metalloproteinase-9 Proteins 0.000 description 1
- 102000005741 Metalloproteases Human genes 0.000 description 1
- 108010006035 Metalloproteases Proteins 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 208000029549 Muscle injury Diseases 0.000 description 1
- 206010073713 Musculoskeletal injury Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102000016611 Proteoglycans Human genes 0.000 description 1
- 108010067787 Proteoglycans Proteins 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 241000219061 Rheum Species 0.000 description 1
- 229910000639 Spring steel Inorganic materials 0.000 description 1
- 206010066218 Stress Urinary Incontinence Diseases 0.000 description 1
- 101710172711 Structural protein Proteins 0.000 description 1
- 208000000260 Warts Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 238000000429 assembly Methods 0.000 description 1
- 230000000712 assembly Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 210000002798 bone marrow cell Anatomy 0.000 description 1
- 210000004271 bone marrow stromal cell Anatomy 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 210000003029 clitoris Anatomy 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 210000001608 connective tissue cell Anatomy 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- 230000036757 core body temperature Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000002638 denervation Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000004980 dosimetry Methods 0.000 description 1
- 210000004177 elastic tissue Anatomy 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 102000034356 gene-regulatory proteins Human genes 0.000 description 1
- 108091006104 gene-regulatory proteins Proteins 0.000 description 1
- 239000003193 general anesthetic agent Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000002962 histologic effect Effects 0.000 description 1
- 238000010562 histological examination Methods 0.000 description 1
- KJZYNXUDTRRSPN-UHFFFAOYSA-N holmium atom Chemical compound [Ho] KJZYNXUDTRRSPN-UHFFFAOYSA-N 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 230000003116 impacting effect Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 210000000281 joint capsule Anatomy 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000009196 low level laser therapy Methods 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000003098 myoblast Anatomy 0.000 description 1
- 101150042523 myod gene Proteins 0.000 description 1
- 239000002121 nanofiber Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000013307 optical fiber Substances 0.000 description 1
- 210000003903 pelvic floor Anatomy 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 229910052761 rare earth metal Inorganic materials 0.000 description 1
- 150000002910 rare earth metals Chemical class 0.000 description 1
- 210000000664 rectum Anatomy 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 230000036332 sexual response Effects 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 230000022379 skeletal muscle tissue development Effects 0.000 description 1
- 201000010153 skin papilloma Diseases 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 210000003699 striated muscle Anatomy 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000036962 time dependent Effects 0.000 description 1
- 238000002691 topical anesthesia Methods 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 239000000522 vaginal cream Substances 0.000 description 1
- 238000002678 vaginoplasty Methods 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H19/00—Massage for the genitals; Devices for improving sexual intercourse
- A61H19/40—Devices insertable in the genitals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/18—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H19/00—Massage for the genitals; Devices for improving sexual intercourse
- A61H19/30—Devices for external stimulation of the genitals
- A61H19/34—For clitoral stimulation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H19/00—Massage for the genitals; Devices for improving sexual intercourse
- A61H19/40—Devices insertable in the genitals
- A61H19/44—Having substantially cylindrical shape, e.g. dildos
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H21/00—Massage devices for cavities of the body, e.g. nose, ears and anus ; Vibration or percussion related aspects A61H23/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H23/00—Percussion or vibration massage, e.g. using supersonic vibration; Suction-vibration massage; Massage with moving diaphragms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H23/00—Percussion or vibration massage, e.g. using supersonic vibration; Suction-vibration massage; Massage with moving diaphragms
- A61H23/02—Percussion or vibration massage, e.g. using supersonic vibration; Suction-vibration massage; Massage with moving diaphragms with electric or magnetic drive
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H23/00—Percussion or vibration massage, e.g. using supersonic vibration; Suction-vibration massage; Massage with moving diaphragms
- A61H23/02—Percussion or vibration massage, e.g. using supersonic vibration; Suction-vibration massage; Massage with moving diaphragms with electric or magnetic drive
- A61H23/0254—Percussion or vibration massage, e.g. using supersonic vibration; Suction-vibration massage; Massage with moving diaphragms with electric or magnetic drive with rotary motor
- A61H23/0263—Percussion or vibration massage, e.g. using supersonic vibration; Suction-vibration massage; Massage with moving diaphragms with electric or magnetic drive with rotary motor using rotating unbalanced masses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0601—Apparatus for use inside the body
- A61N5/0603—Apparatus for use inside the body for treatment of body cavities
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/0625—Warming the body, e.g. hyperthermia treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/067—Radiation therapy using light using laser light
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00005—Cooling or heating of the probe or tissue immediately surrounding the probe
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00559—Female reproductive organs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F2007/0001—Body part
- A61F2007/0048—Genitals
- A61F2007/005—Genitals female
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H2201/00—Characteristics of apparatus not provided for in the preceding codes
- A61H2201/01—Constructive details
- A61H2201/0119—Support for the device
- A61H2201/0153—Support for the device hand-held
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H2201/00—Characteristics of apparatus not provided for in the preceding codes
- A61H2201/02—Characteristics of apparatus not provided for in the preceding codes heated or cooled
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H2201/00—Characteristics of apparatus not provided for in the preceding codes
- A61H2201/02—Characteristics of apparatus not provided for in the preceding codes heated or cooled
- A61H2201/0207—Characteristics of apparatus not provided for in the preceding codes heated or cooled heated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H2201/00—Characteristics of apparatus not provided for in the preceding codes
- A61H2201/02—Characteristics of apparatus not provided for in the preceding codes heated or cooled
- A61H2201/0214—Characteristics of apparatus not provided for in the preceding codes heated or cooled cooled
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H2201/00—Characteristics of apparatus not provided for in the preceding codes
- A61H2201/02—Characteristics of apparatus not provided for in the preceding codes heated or cooled
- A61H2201/0221—Mechanism for heating or cooling
- A61H2201/0228—Mechanism for heating or cooling heated by an electric resistance element
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H2201/00—Characteristics of apparatus not provided for in the preceding codes
- A61H2201/02—Characteristics of apparatus not provided for in the preceding codes heated or cooled
- A61H2201/0221—Mechanism for heating or cooling
- A61H2201/0285—Mechanism for heating or cooling with Peltier elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H2201/00—Characteristics of apparatus not provided for in the preceding codes
- A61H2201/10—Characteristics of apparatus not provided for in the preceding codes with further special therapeutic means, e.g. electrotherapy, magneto therapy or radiation therapy, chromo therapy, infrared or ultraviolet therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H2201/00—Characteristics of apparatus not provided for in the preceding codes
- A61H2201/12—Driving means
- A61H2201/1253—Driving means driven by a human being, e.g. hand driven
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H2201/00—Characteristics of apparatus not provided for in the preceding codes
- A61H2201/16—Physical interface with patient
- A61H2201/1683—Surface of interface
- A61H2201/169—Physical characteristics of the surface, e.g. material, relief, texture or indicia
- A61H2201/1695—Enhanced pressure effect, e.g. substantially sharp projections, needles or pyramids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H2201/00—Characteristics of apparatus not provided for in the preceding codes
- A61H2201/50—Control means thereof
- A61H2201/5023—Interfaces to the user
- A61H2201/5025—Activation means
- A61H2201/5028—Contact activation, i.e. activated at contact with a surface of the user to be treated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H2201/00—Characteristics of apparatus not provided for in the preceding codes
- A61H2201/50—Control means thereof
- A61H2201/5023—Interfaces to the user
- A61H2201/5035—Several programs selectable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H2201/00—Characteristics of apparatus not provided for in the preceding codes
- A61H2201/50—Control means thereof
- A61H2201/5058—Sensors or detectors
- A61H2201/5092—Optical sensor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H2205/00—Devices for specific parts of the body
- A61H2205/08—Trunk
- A61H2205/087—Genitals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0601—Apparatus for use inside the body
- A61N5/0603—Apparatus for use inside the body for treatment of body cavities
- A61N2005/0611—Vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0635—Radiation therapy using light characterised by the body area to be irradiated
- A61N2005/0643—Applicators, probes irradiating specific body areas in close proximity
- A61N2005/0644—Handheld applicators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0659—Radiation therapy using light characterised by the wavelength of light used infrared
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0662—Visible light
Definitions
- This invention relates generally to vaginally-insertable devices, more specifically to vaginal rejuvenation insertable devices.
- VTS Vaginal Relaxation Syndrome
- vaginal wall distension After child birth or with aging, women can experience weakening or relaxing of their vaginal muscles. This relaxation of vaginal muscle is known as Vaginal Relaxation Syndrome (VRS) or vaginal wall distension and it negatively impacts sexual intercourse, can cause intimacy and self-esteem problems, and can lead to urinary incontinence.
- VRS Vaginal Relaxation Syndrome
- a rejuvenation and massage device for the vaginal lumen includes an insertable device that repairs mucosa tissue, such as vaginal tissue, for example after VRS, through vibration, thermal loading, and light emittance for a duration of time.
- the device applies a controlled amount of heat to the subdermal connective tissues surrounding the vaginal mucosa, in particular to the vaginal mucosa of post-parous women who have experienced significant loss of vaginal tone and tissue tension due to tissue stretching, elastase enzyme production, hypoxia, and mechanical stress during birth.
- the mechanism of action is primarily collagenous remodeling within connective tissue surrounding the vaginal canal in a sequential process starting with collagen melting and ending with inflammatory and fibrotic responses generating significant tightening of the vaginal lumen.
- the heat is applied at a temperature range sufficient to induce neocollagenesis, neofibrogenesis, or neoelastogenesis.
- the device also vibrates to provide massage to the tissue, and this vibration may also increase the healing response in the vaginal tissue. The massage induces a pleasure response in the user, making the device enjoyable to use and encouraging longer use of the device.
- the vibration may be applied at a range that provides a pleasure response in the user.
- the vibration may also be applied at a range sufficient to enhance myofibril generation and neocoUagenesis while inducing a pleasure response.
- Low-level laser light (LLLT) therapy can also be used in the device, in some embodiments, to treat the vaginal tissue.
- the light emittance by one or more light emitters is in a range sufficient to prevent apoptosis and cell death, stimulate fibroblast proliferation, migration and collagen synthesis, modulate inflammatory and anti-oxidant responses, and/or simulate angiogenesis and tissue repair in the vaginal tissue.
- the device can be designed to be a convenient at-home use device that can be manipulated by untrained users.
- the device is a handheld device and most or all of the components are integrated within the handheld device.
- the device can have a variety of settings that can be controlled by the user or automatically by the device.
- the user has options to select one or more settings for vibration, thermal loading, and duration of use.
- the device determines settings for vibration, thermal loading using light emitters, and duration to induce neocoUagenesis, neoelastogenesis, and neofibrogenesis.
- the vibration also induces a pleasure response.
- the user selects one or more settings and the device determines additional settings without user selection.
- the device can also be designed to treat localized areas of intravaginal tissue rather than the entire length of the vaginal lumen, thereby increasing the rate of healing from adjacent untreated tissue sites.
- the device can also be used with certain customized lubricants.
- FIGS. 1 A- IB are graphs illustrating data associated with skin repair, in
- FIGS. 1C-1E are examples of a rejuvenation and massage device, in accordance with an embodiment.
- FIG. 2 is a block diagram of components in a rejuvenation and massage device, in accordance with an embodiment.
- FIG. 3 is a block diagram of an inducement environment, in accordance with an embodiment.
- FIG. 4 is a flowchart of a method for inducing neocollagenesis, neoelastogenesis, and neofibrogenesis, in accordance with an embodiment.
- FIG. 5 is a flowchart of a method for vaginal rejuvenation performed by a user of an embodiment of the device, such as in FIGS. 1C-1E, in accordance with an embodiment.
- FIG. 6 is a flowchart of a method for an overall physiological process resulting from use of an embodiment of the device, such as in FIGS. 1C-1E, in accordance with an embodiment.
- Vaginal wall distension has been shown to result in increased expression of the matrix metalloproteases MMP-2 and MMP-9, elastase enzymes expressed predominantly in connective tissue and bone marrow cells (7).
- the elastase enzymes are responsible for destruction of elastin, another important protein such as collagen in connective tissue for establishing the spring-like characteristics of connective tissue. Elastin damage reduces the ability of stretched connective tissue to reconform to the original shape after stretching.
- a micro-balloon is used to stretch the vaginal walls and numerous fragmented and disrupted elastin fibers were seen upon histological examination (7).
- the upregulation of MMP-2 and -9 production after distension was pronounced as seen in Graph 1(a) and Graph 1(b), respectively, as shown in FIG. 1A.
- vaginal wall distention induces increased protease activity and that elastic fiber synthesis is crucial for recovery of the vaginal wall from distention-induced injury.
- Vaginal muscle tissue structures, the vaginal mucosal walls, and the vaginal muscle tissue, like other tissue in the human body, include an extracellular matrix (ECM) of protein fibers and fibroblast cells within the ECM.
- ECM extracellular matrix
- the ECM includes fibers of multiple proteins, including collagen, a primary structural protein such as elastin.
- the collagen protein has a triple helix structure with individual chains held together by hydrogen bonds and provides an elastic, resilient property to tissue due to the individual chains aggregated together, which form fibrils with spring-like tensile properties.
- One method of tightening the ECM includes tightening the collagen fibers by denaturing the fibers.
- Collagen fibers, as well as fibers of other proteins denature and consequently tighten depending on the maximum temperature to which they are exposed.
- the collagen fibrils form random coils (8). If exposed at temperatures only slightly elevated over normal body temperature, the random coil configuration of collagen changes into a more linear configuration through a process called "melting.” This process is time dependent, and is governed by the Arrhenius equation:
- collagen denaturation according to the Arrhenius equation, depends on temperature as well as time, as shown in collagen melting temperature data from live tissues in Graph 2 shown in FIG. 1 A.
- collagen can melt (denature) at a relatively low temperature when exposed for 5 minutes or longer to a thermal load. Melting can occur at or even below core body temperature. The low melting temperature allows collagen molecules to melt and refold locally, providing elasticity and strength in the connective tissue fibers. The low temperature threshold also permits collagen renaturation (refolding) to occur.
- the collagen protein transitions through a significant configuration change where the fibers contract or tighten, in some cases dramatically, and the reconfiguration or denaturation (e.g., shown in a mean change in tissue length of seven treatment groups during testing) is irreversible as seen in Graph 3 shown in FIG. 1 A.
- a collagen fiber can contract to about 40% of the original length of the fiber, and then no further changes are possible despite increases in temperature. Collagen contraction initiates at approximately 60 °C and reaches denaturation by 80 °C as seen in subjective histologic scores for collagen structure of the seven treatment groups (mean +/- SD) in Graph 4 shown in FIG. 1 A. The bars in Graph 4 with differing letters are significantly different from each other (P ⁇ 0.05).
- Neoelastogenesis and neocollagenesis occur within a month after the denaturation (12).
- Neoelastogenesis and neocollagenesis are processes that include remodeling of the ECM as well as integrating new protein fibers, elastin and collagen respectively, in the existing ECM. According to research, these processes initiate seven days after denaturation, a typical timeframe for proliferation of fibroblast cells. The fibroblast cells secrete collagen, assist in the construction of new matrices with the secreted collagen, and effect tissue repair (9). Thermally-induced denaturation will cause contraction of protein fibers and improve tissue tone and connective tissue tension.
- the vibration provides the benefit of massaging the vaginal tissue and providing a pleasure response in the user.
- This additional benefit means that the device may be used more frequently and for a longer period or duration of time, making it easier to have regular, more effective tissue treatments.
- Collagen is known to melt at around 60 °C to 80 °C, though temperatures at 40 °C and above can become uncomfortable to the user. Since a vibrating device is designed to induce pleasure during use, it may be used for a longer period of time. If the time during which heat is applied is extended, it is possible to cause collagen melting at lower temperatures, thus ensuring that the temperatures can remain comfortably within the zone that does not provide pain or discomfort to the user. So, the vibration not only has positive effects on the healing of tissue, but also provides the benefit of making the device enjoyable to use and potentially extending duration of use, allowing for usage of lower temperatures to effect collagen melting, renaturation and subsequent de novo formation.
- LLLT low-level laser light
- Laser light in the deep red portion of the spectrum including some near-infrared portions also prevents apoptosis and cell death, modulates inflammatory and anti-oxidant responses, and stimulates angiogenesis and tissue repair.
- the LLLT effect is specific to small amounts of light and is now a well-accepted modality for repair of musculoskeletal injuries in athletes (21).
- the disclosed device remodels collagen within connective tissue surrounding the vaginal lumen using one or more of thermal loading, vibration, light emittance, and duration.
- Thermal loading remodels the ECM by causing collagen to contract, and vibration and light emittance promote activity of the fibroblasts assisting in collagen matrices remodeling.
- Duration of use can be adjusted depending on the thermal load, or vice versa, to speed up or slow down the thermally-induced denaturation.
- FIGS. 1C-1E are examples of an embodiment of a rejuvenation and therapeutic massage device 100.
- FIG. 1C provides a perspective view of the device 100, including a handle or end 155 of the device 100, an opposite, insertable end 175 of the device, an area or treatment window 170 between ends 155 and 175, and areas 160 and 165 on either side of the window 170.
- FIG. ID is a bottom side diagrammatic view of the device 100 illustrating a user interface, light emitters, and certain internal components.
- FIG. ID illustrates controls or buttons 155A-D, charger 150, light emitting diodes 170A-C, portions 160 and 165 that include sensors, and vibrating device 172 (located at end 175 shown in FIG. 1C).
- FIG. IE is a side view of the device 100, including illustration of the light emitting diodes 170A-C and showing opaque portions 180 and transparent portion 185 of the device 100.
- the device is from 2 - 7 inches long along a vertical axis 105 with a diameter of from 1 - 3 inches along a horizontal axis 110.
- the shape and size of the device 100 may vary.
- a portion of the device, including at least end 175 and window 170, is placed in the vaginal lumen.
- FIG. 2 illustrates components that might be found in the device 100 shown in FIGs. 1C-1E, though more or fewer components can be included.
- the device 100 includes a vibration component 210, a safety temperature component 220, a light emitter component 240, a user interface 250, and a power source 260.
- the device includes a vibration component 210, a safety temperature component 220, a cooling component 230, a light emitter component 240, a user interface 250, and a power source 260.
- the vibration component 210 includes one or more vibration devices 172 (FIG.
- the safety temperature component 220 includes a temperature sensor and/or an optical sensor integrated within a shell of the device and within the device at portions 160 and 165
- the light emitter component 240 includes light-emitting diodes at portion 170 (which forms the treatment window for treating the tissue)
- the user interface 250 is located at a handle end of the device 100, such as end 155.
- the light emitter component 240 in this example, includes one or more light emitting diodes 170B for treatment and one or more light emitting diodes 170A and 170C as visual indicators, as shown in FIG. ID.
- the handle end of the device such as at end 155 includes one or more controls (e.g., buttons) for turning the device on or off (e.g., 155A in FIG. ID), turning light therapy on or off (e.g., 155C in FIG. ID), and for adjusting vibration (e.g., 155B and 155D in FIG. ID).
- controls e.g., buttons
- the light emitter component 240 and user interface are further described below in conjunction with FIG. 2.
- the shell of the device is made of a high-durometer medical- grade silicone material, is water-clear in color, and has a very slight deformability in structure.
- the shell is made of an opaque liquid crystal polymer.
- the shell of the device is made of both a high-durometer medical- grade silicone material and a transparent liquid crystal polymer.
- the shell of the device 100 can be transparent at a location where light- emitting diodes are located in the device (e.g., at portion 185) and opaque at locations where light-emitting diodes are not located, such as portion 180, as illustrated in FIG. IE.
- Portion 185 of the device thus acts as a treatment window and is the area at which light is shone from the device 100 onto tissue inside the vagina to provide treatment to the tissue while the end 175 is inserted in the vagina.
- the device can be water-proof (or water-resistant) and can be resistant to a range of lubricant chemistries.
- the device is thus compatible with use of a customized medical- grade lubricant that matches the refractive index of the optical emitting surface to the tissue surfaces, such as through a water base, maximizing light transmission into the tissue and minimizing loss of light due to scattering.
- the device in FIGS. 1C-1E is designed to be an at home use or as a Class 1 product and does not require trained individuals for use. It is also designed to be ergonomic for comfortable and convenient use. It is further portable, easily cleanable, can be battery- operated, and can be IPXn fluid ingress rated. It may be a handheld device, and some or all of the components can be integrated into or included on the device such that it can be a fully- contained consumer handheld unit.
- FIGS. 1C-1E provide various examples of how the device could be designed.
- Other designs of the device can include components for stimulation of certain aspects of the female anatomy.
- the device might be shaped for or include protrusions that are intended to stimulate the G-spot.
- the device might also include components that extend from the device outside of the vagina intended for stimulation of the clitoris.
- the device can have a variety of massaging features. In some embodiments, it has various vibration settings, including different speeds, tempos or other variations. The vibration settings can also be designed to maximize treatment effectiveness, including generation of the improved healing response caused by vibration. Certain aspects of the device can be designed to rotate or otherwise move to provide massage.
- the device can include a handle or portion that is gripped by the hand of the user for easy insertion and manipulation, such as handle portion 155 in FIG. 1C, and some or all of the remaining portion of the device can be insertable into the vagina.
- FIG. 2 is a block diagram of the components in the rejuvenation and therapeutic massage device in accordance with the embodiment shown in FIG. 1C.
- FIG. 2 is a block diagram of the components in the rejuvenation and therapeutic massage device in accordance with the embodiment shown in FIG. 1C.
- the device may include different and/or additional components than those shown in FIG. 2 and the component may include different and/or additional features than those described herein.
- the vibration component 210 applies vibration to the vaginal tissue in contact with the device.
- the vibration component 210 includes one or more motors and one or more counterweights configured to operate in a 5-10 Hz range, in an 8-10 Hz range, or at any frequency from 0-15 kHz (though it can also operate in other similar ranges, as desired).
- one motor can operate in a frequency less than 10 Hz to provide vaginal rejuvenation and one or more other motors can operate in a frequency of up to 15 kHz to induce pleasure.
- a single motor provides both vaginal rejuvenation and induces pleasure.
- the vibration component 210 vibrates in whatever range is determined to produce effective myofibril generation and collagen production.
- the one or more motors and one or more counterweights may be flexibly coupled to the one or more portions of the inner wall of the shell of the device.
- the one or more motors and one or more counterweights are coupled to the one or more portions of the inner wall of the shell to maximize surface deflection or maximize offset of the shell to the one or more motors and one or more counterweights.
- the one or more motors and one or more counterweights may be coupled inline and paired, providing phases of vibration patterns along the vertical axis 105 of the device.
- the phases of vibration patterns can be options presented to the user through an external user interface 250.
- Various vibration patterns can be selected through the user interface 250, as further described below in conjunction with FIG. 3.
- the vibration component 210 may be coupled to the device to produce vibration along the vertical axis 105 of the device or along the horizontal axis 110 of the device (off-axis movement from the vertical axis 105).
- the vibration component 210 includes a high-efficiency resonant drive mechanism, reducing power required to operate the device.
- the high- efficiency resonant drive mechanism includes a rare-earth magnetic stator surrounded by laminated armature pieces directing magnetic lines of flux to a spring-steel rotor.
- the armature includes anti-sense coils and the anti-sense coils periodically and continuously imbalance the magnetic force directed by the armature towards the rotor, causing the rotor to deflect in the direction of applied force.
- the resonant drive mechanism is configured for resonant operation at any desired frequency, with a preferred range of 5 - 10 Hz.
- the resonant drive mechanism can also be configured for resonant operation in an 8-10 Hz range, or at any frequency from 0-15 kHz.
- one resonant drive mechanism can operate in a frequency less than 10 Hz to provide vaginal rejuvenation and one or more other resonant drive mechanism can operate in a frequency of up to 15 kHz to induce pleasure.
- a primary attribute of the high-efficiency resonant drive mechanism is that the high-efficiency resonant drive mechanism uses little drive energy for comparatively large mechanical deflections, has no moving or sliding parts which can wear, and includes simple construction not requiring expensive components.
- the high-efficiency resonant drive mechanism's rotor is flexibly coupled to the outer walls of the device configured to maximize surface deflection or vibration of key, circumscribed portions of the device, rather than the entire device by default.
- the flexible coupling maximizes energy coupling to the vaginal mucosa rather than to the hand of a user of the device.
- the vibration component 210 includes additional external motors and one or more counterweights attached to an external additional appendage of the device (not shown).
- the safety temperature component 220 includes a thermal overload detection including one or more thermocouples, thermal detectors, cutoffs, optical detectors, or other suitable temperature readers or detectors. Therefore, if the temperature of the human mucosa tissue exceeds a threshold temperature as detected by the safety temperature component 220, then the inducement generator 350, described further below in conjunction with FIG. 3, adjusts instructions sent to the light emitter component 240 to lower or turn off LEDs and, therefore, lower temperature through control of emission of the LEDs.
- the safety temperature component 220 may also include a safety interlock including a heat sensor in the shell of the device that can detect human tissue (e.g., mucosa tissue) through temperature.
- the safety interlock includes infrared sensors or other suitable sensors able to detect human tissue in contact with the outer wall of the shell of the device. The safety interlock can prevent the device, such as through the light emitter component 240, from emitting light or reduce intensity of emitted light if the device is not in contact with the vaginal tissue within the vaginal lumen or equivalent.
- the safety temperature component 220 can also heat the vaginal tissue in contact with the device to induce neocollagenesis.
- the safety temperature component 220 is configured to operate in the range of 35 °C - 80 °C to, for example, measure temperature of the shell of the device and/or vaginal mucosa in contact with the shell of the device up to a depth of 7 mm of the vaginal mucosa in contact with the shell of the device, and to allow production of heat preferably to a depth of 5 mm or more on vaginal tissue in contact with the outer wall of the shell of the device, such as the vaginal mucosa.
- the function of the safety temperature component 220 is performed to assist the light emitter component 240.
- the light emitter component 240 can provide a steady emission of light and thus thermal load while the safety temperature component 220 heats to keep temperature in a temperature range that can be specified by the user or by a protocol stored in memory 360 on the device.
- the safety temperature component 220 is configured to operate for 1 to 10 minutes, though longer or shorter time periods can be used, as well.
- the safety temperature component 220 operates for as long as a user is comfortable and shuts off or cycles at a set temperature when a threshold temperature is reached.
- the safety temperature component 220 operates for a duration of time dictated by treatment and prior usage. For example, if treatment includes a protocol for use of the device three times a week, each time using the device for 8-10 minutes, the safety temperature component 220 can operate for 8-10 minutes.
- the safety temperature component operates in a temperature or range of temperature that is determined to produce heat to a depth that permits collagen melting and repair.
- the safety temperature component 220 is configured to be able to treat localized areas of vaginal tissue as well as the entire length of the vaginal tissue along the vaginal lumen. Treating localized areas of vaginal tissue allows for a rate of healing higher than when treating the entire length of the vaginal tissue due to assistance from adjacent untreated tissue sites along the vaginal lumen.
- the localized areas of vaginal tissue being treated can be selected manually or automatically.
- the user can use a sliding button with a plurality of notches corresponding to localized areas along the vertical axis 105 of the device.
- the safety temperature component 220 selects localized areas along the vertical axis 105 of the device based on one or more programmed patterns stored in memory 360.
- the device includes a cooling component 230 that cools the vaginal tissue in contact with the device, minimizing the user's perception of thermal load from the device on the vaginal tissue.
- the cooling component 230 can help maintain a temperature of the device in a range or below a threshold temperature.
- the cooling component 230 includes a coaxial external sheath containing cryogenic fluid, minimizing epithelial heat load.
- the cooling component 230 includes one or more Peltier cooling devices integrated into the inner wall of the shell of the device.
- the cooling component 230 includes a cooling apparatus peripheral to the inner wall of the shell of the device, minimizing heat load by passive conduction to the inner wall of the shell of the device and then to a heat-pipe assembly.
- Another embodiment includes a liquid coolant, such as nontoxic propylene glycol in water, which directs excess thermal energy from the light emitter component 240 to a heat exchanger located at one end of the device.
- the cooling component 230 is configured to cool the vaginal tissue in contact with the device to below 40 °C, though it can also be designed to cool to higher or lower temperatures, as desired.
- the cooling component 230 is an optional component and may or may not be required depending on the safety temperature component 220.
- the light emitter component 240 emits light in a spectrum range sufficient to prevent apoptosis and cell death, stimulate fibroblast proliferation, migration and collagen synthesis, modulate inflammatory and anti-oxidant responses, and simulate angiogenesis and tissue repair in the vaginal tissue.
- the light emitter component 240 can also emit light in a visible spectrum as a visual indicator to provide a user a visual indication in a treatment window 185 that light is being emitted in a spectrum range sufficient to prevent apoptosis and cell death, stimulate fibroblast proliferation, migration and collagen synthesis, modulate inflammatory and anti-oxidant responses, and simulate angiogenesis and tissue repair in the vaginal tissue.
- a visual indicator can also be included in a handle 155 portion of the device 100 to provide the user an additional visual indicator that is visible during use of the device 100.
- the light emitter component 240 is configured to apply thermal load of 150 mW/cm 2 to a penetration depth of 3-5 mm or up to 7 mm on vaginal mucosa surrounding the device and is controlled based on temperature readings taken by the safety temperature component 220.
- the light emitter component 240 can also emit light in a range of 250-400 nm for disinfection or sterilization purposes.
- Light emitted in the range of 250-400 nm can kill bacteria and prevent infection, such as yeast infection, during use of the device.
- the light emitted in the range of 250-400 nm can sterilize and kill bacteria in the vaginal tissue along the treatment portion of the device such as portionl85 in FIG. IE, along the device itself inserted in the vagina, or both. Thus, this light emitted can act to kill bacteria on the tissue and or on the device.
- the light emitted in the range of 250-400 nm can be through one or more light emitting diodes (LEDs) that emit light in this range.
- LEDs light emitting diodes
- the device can include up to 20 LEDs emitting light in this range and they can be placed in the treatment portion of the device 185.
- These can be light emitters added in addition to the light emitters shown in, for example, FIG. IE, or some of the light emitters in FIG. IE could emit light in this disinfection range, or the light emitters can be configured to switch between treatment and disinfection emission ranges by control of the user, by automated setting of the device, at certain time ranges (e.g., disinfection for a period of time at the beginning or end of a treatment cycle), etc.
- the light emitter component 240 emits light using one or more light emitting diodes (LED). In other embodiments, the light emitter component 240 emits light using electric lamps, incandescent lamps, other electroluminescent lamps, or lasers.
- the light emitter component 240 is configured to emit light in the 600-1000 nm range, including the red portion and the near-infrared light portion of the spectrum, resulting in of the production of low-level laser light therapy.
- the light emitter component 240 can be designed to emit light in other ranges, as well, including less than or equal to 690 nm such as the visible spectrum.
- the emitted light is capable of applying thermal load on vaginal mucosa surrounding the device and light emitted in the visible spectrum provides an indication that the emitted light is applying thermal load in the non-visible spectrum.
- the light emitter component 240 includes one or more rings of optic segments such as light emitting diodes creating a helicopter optic configuration allowing radial distribution of light to the surrounding visual tissue in contact with the shell or a portion of the shell of the device.
- the light emitted from the device is emitted in a toroid shape or ring to illuminate a portion of the vaginal cavity rather than illuminating the entire vaginal cavity.
- the light emitted from the device is from a plurality of emitters coupled to the device.
- the plurality of emitters can be configured as lines or rows of emitters along the vertical axis 105 of, horizontal axis 110 of, or at a diagonal across the device or a portion of the device.
- the plurality of emitters can be configured as rings along the horizontal axis 110, the rings placed next to each other along the vertical axis 105.
- the device includes manual or automatic click-by-click positionability in the vertical (axial) direction of this radial optic portion of the device, so that different axial stations within the vaginal mucosa may be treated at different points in time.
- it can include automated, repetitive vertical (axial) motion of this radial optic portion of the device, so that different axial stations within the vaginal mucosa may be treated in rapid sequence during the same treatment session.
- the light emitter component 240 includes one or more rings of a plurality of light emitting diodes that can move along the vertical axis 105 of the device.
- the position of the one or more rings of the plurality of light emitting diodes can be manually selected by the user.
- the user can use a sliding button with a plurality of notches corresponding to positions along the vertical axis 105 of the device to select position of the one or more rings.
- the light emitter component 240 selects positions along the vertical axis 105 of the device based on one or more programmed patterns stored in memory 360.
- the one or more rings emitting light may be configured to apply thermal load on vaginal mucosa surrounding the device or a portion of the device.
- the emitted light is provided by an external light source or box piping in light through one or more assemblies or bundles of optical fiber cables.
- the emitted light is provided by a central light emitter at one end of the device operating via free-space optical communication and directing light along the vertical axis 105, resulting in light exiting radially out of the transparent section peripheral to the inner wall of the shell of the device towards the vaginal tissue in contact with the shell of the device.
- the inner wall of the shall may include a conical reflector including angled sides configured to reflect light such that the light is emitted radially out of the device towards the vaginal mucosa surrounding the device at an angle. The angle, for example, is normal to the outer shell of the device.
- the user interface 250 includes one or more buttons or controls for powering the device, selecting a vibration setting, turning on or off light therapy via LEDs, and turning on or off a light indicator setting in one embodiment.
- the user interface 250 includes one or more buttons or controls for selecting a vibration setting, selecting a temperature setting, a duration setting, a temperature position setting, a light emitted position setting, or any combination thereof, though some embodiments may include only a subset of these settings or may include additional settings.
- the buttons may include sliding buttons with notches, pushbutton switches, switches, joysticks, keypads, tactile buttons, toggle switches, rocker switches, slide switches, trackballs, microswitches, or other types of controls.
- buttons or controls are at least greater than half a centimeter in diameter and of a color contrasting a color of the material of the device for visibility.
- the user interface 250 can also include a visual indicator via one or more LEDs indicating status of treatment such as whether treatment is currently happening, treatment duration, temperature associated with treatment, or any other suitable indicator of treatment via light therapy, vibration, or any combination thereof.
- the visual indicator can turn on if treatment is occurring and turn off if treatment is not occurring.
- the visual indicator can also be a bar and how much of the bar is lit up using LEDs can indicate duration of treatment (e.g., in minutes) or temperature of treatment (e.g., indicates whether temperature is too low, just right, or too high).
- the power source 260 in one embodiment, includes a low voltage power line from the device to a plug-in wall transformer. In other embodiments, the power source 260 includes a radio frequency or other charging apparatus built into the device and one or more batteries. Thus, the power source 260 can couple to a charging apparatus or charger through a universal serial bus (USB) connection such as a Micro-B plug, UC-E6 proprietary (non- USB) plug, Mini-B plug, Standard-A receptacle, Standard-A plug, Standard-B plug, micro USB or any other suitable connector including one or more pins necessary to charge the device.
- the charging apparatus can be configured to couple to a wall wart alternating current (AC) plug.
- AC alternating current
- ID is one example of such a charger.
- Other charging systems can also be used.
- the device might use replaceable batteries, might be wirelessly or inductively charged via a base that includes a transmitting coil that magnetically couples with a receiving coil in the device to induce current in the receiving coil and charge the device.
- Some embodiments include a rejuvenation and massage device capable of stimulating neocollagenesis and neoelastogenesis factors, while simultaneously engaging the female sexual response in order to maximize likelihood of repeated use of the product and thence assure clinical benefit.
- Some embodiments include a rejuvenation and massage device based on the combination of light energy to effect collagen melting, denaturation and remodeling.
- Further embodiments include a rejuvenation and massage device based on the combination of light energy to effect collagen melting, denaturation and remodeling, with simultaneous vibration designed to enhance subsequent myofibril generation and
- Additional embodiments include a rejuvenation and massage device based on the combination of light energy to produce an LLLT effect.
- the device can also be a
- any of these device designs can be enhanced by being used in association with a customized medical-grade lubricant, designed to match the refractive index of the optical emitting surface to the tissue surfaces in order to maximize light transmission into the tissue and minimize optical scattering loss.
- any of these designs can also be over-the-counter, Class 1 devices to effect light- assisted vaginal rejuvenation, (as opposed to bulky, expensive, professional clinical units).
- any of these designs can include a high-efficiency resonant drive mechanism based on periodically-unbalanced permanent-magnetic fields, designed to minimize electrical loss while maximizing transmission of mechanical vibration to selected portions of the device structure.
- the device disclosed in FIGS. 1 and 2 can be modified to include
- Neocollagenesis Neoelasto genesis
- Neofibrogenesis Neofibrogenesis
- FIG. 3 is an example of an embodiment of an inducement environment 300 for inducing neocollagenesis, neoelastogenesis, and neofibrogenesis.
- the inducement environment 300 includes an inducement system 301 and user selected settings 380 as an input to the inducement system 301.
- the inducement system 301 includes software modules including a vibration module 310, a temperature module 320, a light emitter module 330, a duration module 340, an inducement generator 350, memory 360 and a processor 370.
- the inducement system 301 receives the user selected settings 380 and, based on the user selected settings 380, determines range of vibration, duration of use, range of thermal load, and amount of emitted light to ensure inducement of neocollagenesis, neoelastogenesis, and neofibrogenesis.
- the inducement system 301 includes additional and/or alternative components than the components shown in FIG. 3.
- the user selected settings 380 include a vibration setting, a temperature setting, a duration setting, a temperature position setting, a light emitted position setting, or any combination thereof.
- the user selected settings 380 are sent to the inducement generator 350 to be sent to the other modules in the inducement system 301.
- the user selected settings 380 are sent directly to the corresponding modules.
- the vibration setting is sent to the vibration module 310, the temperature setting to the temperature module 320, the duration setting to the duration module 340, the temperature position setting to the temperature module 320, and the light emitted position setting to the light emitter module 330.
- Example vibration settings include a low setting, medium setting, and a high setting for a plurality of patterns including no vibration, constant vibration, pulse vibration, and wave vibration.
- the low, medium and high setting increase strength of vibration for the plurality of patterns.
- Example temperature settings include various percentages of LEDs being turned on (e.g., 0%, 25%, 50%, 75%, 100%, etc.).
- Example duration settings include how many minutes to turn the vibration and/or temperature on such as 1 minute, 5 minutes, 10 minutes, etc.
- Temperature position settings and light emitted position settings can be optionally provided and include options to indicate which portion of LEDs to turn on or off and, in the embodiment where the safety temperature component 220 provides heat as well, which portion of the device to provide additional heat from the safety temperature component 220.
- the inducement generator 350 determines settings for the corresponding modules that it sends as instructions to the corresponding modules. For example, if the user has only selected one setting, the inducement generator 350 determines settings for the other modules based on the one selected setting. For example, if the user has selected a vibration setting, depending on the frequency of the setting or a protocol for treatment, the duration can be decreased if the vibration frequency is higher than a threshold frequency or can be increased if the vibration frequency is lower than the threshold frequency. If the user has selected a temperature setting, the duration can be increased or decreased based on whether or not the selected temperature is lower than or higher than a threshold temperature, respectively.
- the temperature setting can be set above or below a threshold temperature based on whether or not the interval of time selected is below or above a threshold interval of time.
- the duration setting is not an option available to the user and has a default run time, such as 5 minutes.
- the vibration setting can also be set dependent on the conditions of the duration setting.
- the vibration module 310 receives instructions for a vibration setting from the inducement generator 350, according to one embodiment.
- the vibration module 310 applies a selected vibration setting, if the user selected a vibration setting, or a default vibration setting in a range of 5-10 Hz if no vibration setting is selected by the user. In one
- the default vibration setting includes vibration in the range of 5 - 10 Hz and vibration in the range of 1-15 kHz.
- the temperature module 320 receives instruction for a temperature setting from the inducement generator 350, according to one embodiment. If the user has selected a temperature setting, the temperature module 320 turns on or off one or more LEDs of the light emitter component 240. In another embodiment where the safety temperature component 220 and the cooling component 230 are included in the device, the temperature module 320 also adjusts thermal load and cooling to maintain the thermal load in the selected temperature setting. The temperature module 320 maintains the thermal load applied by the light emitter component 240, the thermal load component 220, the cooling component 230, or any combination thereof such that temperature induced by the thermal load is in a range of 35 °C - 80 °C or 35 °C - 41 °C as a default.
- the temperature module 320 may maintain the thermal load such that the temperature induced is in the desired range through a local dosimetry device. If the received instruction includes a temperature position setting, the temperature module 320 sends instructions regarding position to the light emitter component 240, the safety temperature component 220, or any combination thereof in various embodiments. The temperature module 320 will detect thermal overload and automatically shut down the device if thermal overload is detected.
- the light emitter component 240 of the device provides a radiative thermal load from the light emission to penetrate and stimulate the tissue to a depth of 5mm and, thus, the device also provides a conductive thermal load to tissue directly in contact with the device.
- the heat generated by the light emitter component 240 will heat the device and thus the shell of the device.
- the shell of the device is maintained at an acceptable temperature that can be monitored by the device (e.g., by the safety temperature component 220).
- the temperature of the shell of the device can also be high enough to warm cells in the vaginal mucosa at a depth of 3 to 5mm with the transfer of energy from the radiative warming via the light emitter component 240.
- the safety temperature component 220 can also include a temperature sensor that monitors temperature of vaginal mucosa at a depth of up to 7 mm.
- the temperature sensor can monitor temperature in the range of 60 °C - 80 °C, which enhances collagen rejuvenation.
- the light emitter module 330 emits light in designed wavelengths including red and/or near-infrared portions of the spectrum lying between 600 - 1,000 nm as well as in the visible light spectrum. In another embodiment, light is emitted at wavelengths covering a spectral range of 635 - 980 nm as well as in the visible light spectrum. In yet another embodiment, light is emitted at wavelengths covering a spectral range of 670 - 810 nm as well as in the visible light spectrum, and in another embodiment, light is emitted at singular wavelengths alone, such as 670 nm or 808 nm as well as in the visible light spectrum.
- the light emitter module 330 determines the position of the ring-optics along the vertical axis 110 of the device. In one embodiment, the position may be determined automatically to ensure continuous exposure of the vaginal tissue in contact with the device to the emitted light. In another embodiment, the user selects the light emitted position setting. Then, the light emitter module 330 repositions the ring-optics according to the light emitted position setting.
- the device can also be programmed via instructions in memory 360 to emit light in the visible spectrum responsive to light in the non- visible spectrum being emitted. Therefore, the user has a visual indicator indicating emission of light in the non- visible spectrum.
- the duration module 340 counts clock cycles while the device is in use. If the user has selected a duration setting, the duration module 340 will shut down the device after the corresponding number of clock cycles has been reached or gives an indication once the duration setting has been reached. Alternatively, based on protocol for treatment and therapy as stored in the memory 360 of the device, the duration module 340 shuts down a function of the device (e.g., vibration, light emission, etc.) if a threshold duration as dictated by the protocol is reached.
- a function of the device e.g., vibration, light emission, etc.
- the inducement system 301 includes a memory 360 and a processor 370.
- the memory 360 includes a non-transitory computer-readable storage medium that stores computer-executable instructions for carrying out the functions attributed to the inducement system 301.
- the memory 360 may additionally store settings and default settings for the vibration component, safety temperature component, light emitter component, and duration component. The default settings can be dictated by a protocol for treatment and therapy.
- the processor 370 processes data signals and may include various computing architectures including a complex instruction set computer (CISC) architecture, a reduced instruction set computer (RISC) architecture, or an architecture implementing a combination of instruction sets. Although only one processor is shown in FIG. 3, multiple processors may be included.
- the processors can include an arithmetic logic unit, a microprocessor, a general purpose computer, or some other information appliance equipped to transmit, receive and process electronic data signals from the memory 360 and other devices both shown and not shown in the figures.
- the processor 370 loads and executes the instructions stored in the memory 360 to carry out the inducement process described herein. An embodiment of a process performed by the inducement system 301 is described further below in conjunction with FIG. 4.
- FIG. 4 is a flowchart of one embodiment of a method 400 for vaginal
- the method may include different and/or additional steps than those shown in FIG. 4.
- the functionality described in conjunction with the inducement environment 300 in FIG. 3 may be provided by the inducement generator 350 in the inducement system 301 or may be provided by any other suitable component, or components, in other embodiments.
- the method 400 is a sequential process starting with remodeling of the ECM including collagen and elastin and ending with effecting fibrotic responses to assist in remodeling of the ECM, consequently tightening the vaginal tissue and vaginal lumen.
- the method 400 remodels the ECM while simultaneously effecting fibrotic responses to assist in remodeling the ECM and
- An indication is received 410 by the inducement system 301 that a user has activated the rejuvenation and massage device.
- the indication may include notification that the device has been placed into contact with vaginal tissue from a sensor used to detect contact between the device and vaginal tissue.
- Contact of vaginal tissue with the device or presence of vaginal tissue within a threshold distance with the device can also be detected using optical sensors, capacitive sensors (detecting capacitive proximity), as well as any other suitable proximity sensor.
- the indication could also be a notification that the user has turned on the device or activated a particular setting.
- Setting selections are received 420 (e.g., from the user or from a controller in the device itself if the device is automatically providing settings) to control a mechanism of the device.
- the user may select a vibration speed or pattern.
- no setting selections are selected by the user and, in another embodiment, one or more setting selections are selected.
- the setting selection by the user is a default selection for the device.
- the device itself can also determine the setting, so the setting might be received 420 from a component or controller in the device. Based on the setting selections, vibration, thermal load, and duration are determined 430. If the user has selected a vibration setting, the device will vibrate at the selected vibration setting.
- the device will thermally load the surrounding vaginal tissue at the thermal load setting via the light emitter component 240, the safety temperature component 220, the cooling component 230, or any combination thereof. If the user has selected a duration setting, the device will operate for the selected duration setting.
- the device will institute the setting.
- a default setting for each setting with no user setting selection will be determined. Instructions including the determined settings for vibration, thermal load, and duration as well as light emittance are sent 440.
- FIG. 5 is a flowchart of one embodiment of a method 500 for vaginal rejuvenation performed by a user of the device.
- a device such as or an embodiment of the device described in FIGS. 1C-1E with one or more components as described in FIG. 2, is provided 510.
- the user provides 510 the insertable vaginal rejuvenation device (e.g., one of the devices described above or other devices) and contacts 520 at least one contact surface of the insertable device with mucosa tissue such as vaginal tissue.
- the user selects 530 at least one setting selection on the user interface of the device.
- the selections available to the user include a vibration setting, a temperature setting, a duration setting, a temperature position setting, a light emitted position setting, and any combination thereof, as described with regard to FIG. 3.
- the user activates 540 the device.
- the user activates 540 one or more settings indicating turning on vibration, light emission, or any combination thereof.
- FIG. 6 is a flowchart of one embodiment of a method 600 for the overall physiological process resulting from use of a device of any of the embodiments described in FIGS. 1C-1E.
- Thermal load is produced 610 to the vaginal tissue through light emission on the vaginal tissue and vibration is applied 620 to the vaginal tissue. All of these steps may be performed or only one or two of these steps may be performed.
- the thermal load is produced 610 at a sufficient rate to effect a temperature within the deep vaginal mucosa ranging from 35°C - 80 °C, and more particularly between 35°C - 41 °C and/or 60 °C-80 °C, as described in FIG. 3.
- the light is emitted in a range of 600-1000 nm as well as in the visible light spectrum, as described in FIG. 3.
- vibration is applied 620 at a range of 1-15 kHz and can also be applied 620 at a range of 5-10 Hz.
- Producing 610 thermal load by emitting light and applying 620 vibration at a range of 5-10 Hz for a sufficient duration of time induces 630 neocollagenesis, neofibrogenesis, or neoelastogenesis.
- applying 620 vibration at a range of 1-15 kHz induces 630 a pleasure response in the vaginal tissue.
- the induced pleasure response results in a lengthening 640 of the duration of time during which the thermal load is produced 610 to the vaginal tissue relative to the duration of time that thermal load could be produced 610 without the induced 630 pleasure response.
- a software module is implemented with a computer program product including a computer-readable medium containing computer program code, which can be executed by a computer processor for performing any or all of the steps, operations, or processes described.
- the apparatus described herein may be specially constructed for the required purposes, and/or it may include a general-purpose computing device selectively activated or reconfigured by a computer program stored in the computer.
- Such a computer program may be stored in a non-transitory, tangible computer readable storage medium, or any type of media suitable for storing electronic instructions, which may be coupled to a computer system bus.
- any computing systems referred to in the specification may include a single processor or may be architectures employing multiple processor designs for increased computing capability.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Rehabilitation Therapy (AREA)
- Reproductive Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Pathology (AREA)
- Heart & Thoracic Surgery (AREA)
- Physics & Mathematics (AREA)
- Vascular Medicine (AREA)
- Otolaryngology (AREA)
- Surgery (AREA)
- Optics & Photonics (AREA)
- Electromagnetism (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Percussion Or Vibration Massage (AREA)
- Radiation-Therapy Devices (AREA)
Priority Applications (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA2930252A CA2930252C (en) | 2013-11-11 | 2014-11-11 | At-home light-emitting diode and massage device for vaginal rejuvenation |
| CN201480072622.3A CN105899180B (zh) | 2013-11-11 | 2014-11-11 | 用于阴道复原的家用发光二极管和按摩设备 |
| KR1020167015571A KR20160086374A (ko) | 2013-11-11 | 2014-11-11 | 질 성형을 위한 가정용 발광 다이오드 및 마사지 장치 |
| JP2016529993A JP6772061B2 (ja) | 2013-11-11 | 2014-11-11 | 家庭用の膣再活性化のための発光ダイオードおよびマッサージデバイス |
| AU2014346372A AU2014346372A1 (en) | 2013-11-11 | 2014-11-11 | At-home light-emitting diode and massage device for vaginal rejuvenation |
| EP14860017.4A EP3068361B1 (en) | 2013-11-11 | 2014-11-11 | At-home light-emitting diode and massage device for vaginal rejuvenation |
| CN201910638348.6A CN110353965B (zh) | 2013-11-11 | 2014-11-11 | 用于阴道复原的家用发光二极管和按摩设备 |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361902730P | 2013-11-11 | 2013-11-11 | |
| US61/902,730 | 2013-11-11 | ||
| US14/537,869 US9949889B2 (en) | 2013-11-11 | 2014-11-10 | At-home light-emitting diode and massage device for vaginal rejuvenation |
| US14/537,869 | 2014-11-10 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2015070242A2 true WO2015070242A2 (en) | 2015-05-14 |
| WO2015070242A3 WO2015070242A3 (en) | 2015-10-29 |
Family
ID=53042360
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/US2014/065069 WO2015070242A2 (en) | 2013-11-11 | 2014-11-11 | At-home light-emitting diode and massage device for vaginal rejuvenation |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US9949889B2 (zh) |
| EP (1) | EP3068361B1 (zh) |
| JP (1) | JP6772061B2 (zh) |
| KR (1) | KR20160086374A (zh) |
| CN (2) | CN105899180B (zh) |
| AU (1) | AU2014346372A1 (zh) |
| CA (1) | CA2930252C (zh) |
| WO (1) | WO2015070242A2 (zh) |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017058957A1 (en) * | 2015-10-02 | 2017-04-06 | Joylux, Inc. | A light-emitting diode and massage device for delivering focused light for vaginal rejuvenation |
| ITUB20155010A1 (it) * | 2015-11-02 | 2017-05-02 | Andrea Recchi | Dispositivo per il trattamento di tessuti umani |
| US9949889B2 (en) | 2013-11-11 | 2018-04-24 | Joylux, Inc. | At-home light-emitting diode and massage device for vaginal rejuvenation |
| USD829922S1 (en) | 2017-05-12 | 2018-10-02 | Filip Sedic | Vaginal rejuvenation device |
| EP3405158B1 (de) | 2016-10-05 | 2019-12-25 | Novoluto GmbH | Verbesserte stimulationsvorrichtung |
| US11090220B2 (en) | 2013-09-23 | 2021-08-17 | Novoluto Gbhh | Stimulation device |
| DE202021104579U1 (de) | 2020-11-20 | 2022-02-23 | Medlight Gmbh | Liebeskugel |
| WO2022090787A1 (en) | 2020-11-02 | 2022-05-05 | Savantini Limited | An exercise system |
| US11896823B2 (en) | 2017-04-04 | 2024-02-13 | Btl Healthcare Technologies A.S. | Method and device for pelvic floor tissue treatment |
Families Citing this family (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2477695T3 (en) | 2009-09-18 | 2016-01-25 | Viveve Inc | vaginal omformningsanordning |
| US20150112231A1 (en) | 2011-11-28 | 2015-04-23 | Remendium Labs Llc | Treatment of fecal incontinence |
| CA2862928A1 (en) | 2012-01-30 | 2013-08-08 | Remendium Labs Llc | Treatment of pelvic organ prolapse |
| EP3091932A4 (en) | 2014-01-06 | 2017-09-13 | Remendium Labs LLC | System and method for kegel training |
| CN104941072A (zh) * | 2015-06-10 | 2015-09-30 | 上海世湖材料科技有限公司 | 一种智能遥控led阴道仪 |
| USD772419S1 (en) | 2015-07-01 | 2016-11-22 | Joylux, Inc. | Rejuvenating massage device |
| USD772422S1 (en) * | 2015-09-08 | 2016-11-22 | LELO Inc. | Personal massager |
| US11484724B2 (en) * | 2015-09-30 | 2022-11-01 | Btl Medical Solutions A.S. | Methods and devices for tissue treatment using mechanical stimulation and electromagnetic field |
| USD773061S1 (en) | 2015-10-02 | 2016-11-29 | Joylux, Inc. | Light-emitting diode and rejuvenating massage device |
| CN106178273B (zh) * | 2016-07-12 | 2018-07-31 | 圆融健康科技（深圳）有限公司 | 光子治疗仪 |
| CN106178272B (zh) * | 2016-07-12 | 2018-09-14 | 圆融健康科技（深圳）有限公司 | 光子治疗仪及其控制方法 |
| US20190083809A1 (en) | 2016-07-27 | 2019-03-21 | Z2020, Llc | Componentry and devices for light therapy delivery and methods related thereto |
| JP7242524B2 (ja) | 2016-07-29 | 2023-03-20 | レノビア インコーポレイテッド | 骨盤底筋をトレーニングするためのデバイス、システムおよび方法 |
| CN106178279B (zh) * | 2016-08-05 | 2018-09-14 | 圆融健康科技（深圳）有限公司 | 介入式紫外光治疗仪及其控制方法 |
| KR101772687B1 (ko) * | 2016-09-26 | 2017-08-29 | 연세대학교 원주산학협력단 | 생식 기관 자극 장치 및 그의 구동 방법 |
| CN106362304B (zh) * | 2016-09-28 | 2018-12-11 | 圆融健康科技（深圳）有限公司 | 智能光子治疗仪及其控制方法 |
| US11511110B2 (en) | 2018-06-27 | 2022-11-29 | Viveve, Inc. | Methods for treating urinary stress incontinence |
| SE541782C2 (sv) * | 2017-03-08 | 2019-12-17 | Rikard Almgren | Anordning för stimulering |
| CN109069857A (zh) * | 2017-03-08 | 2018-12-21 | 拉尔夫·齐珀 | 用于治疗骨盆痛、慢性前列腺炎、和或膀胱过动症的症状的方法 |
| JP2020529298A (ja) * | 2017-07-27 | 2020-10-08 | セルン コーポレイションＣｅｒｎ Ｃｏｒｐ． | 光ベースの膣治療装置 |
| WO2019084469A1 (en) | 2017-10-27 | 2019-05-02 | Renovia Inc. | DEVICES, SYSTEMS, AND METHODS FOR PELVIC FLOOR MUSCLE TRAINING |
| US10307330B1 (en) * | 2017-11-16 | 2019-06-04 | Filip Sedic | Skincare devices and methods of use |
| KR101914068B1 (ko) * | 2018-01-18 | 2018-11-01 | 김유인 | 휴대용 여성 질 청결장치 |
| KR102198488B1 (ko) * | 2019-01-10 | 2021-01-05 | 전경천 | 부인과 질환 치료 장치 |
| US11571357B2 (en) | 2019-01-29 | 2023-02-07 | Joylux, Inc. | Vaginal health diagnostics |
| EP3705106B1 (de) * | 2019-03-07 | 2022-01-05 | Novoluto GmbH | Einführbare stimulationsvorrichtung |
| USD888948S1 (en) | 2019-04-02 | 2020-06-30 | Renovia Inc. | Intravaginal device |
| USD898911S1 (en) | 2019-04-03 | 2020-10-13 | Renovia Inc. | Intravaginal device assembly |
| USD889649S1 (en) | 2019-04-05 | 2020-07-07 | Renovia Inc. | Intravaginal device |
| USD896958S1 (en) | 2019-04-11 | 2020-09-22 | Renovia Inc. | Intravaginal device |
| USD899593S1 (en) | 2019-04-12 | 2020-10-20 | Renovia Inc. | Intravaginal device |
| USD896959S1 (en) | 2019-04-23 | 2020-09-22 | Renovia Inc. | Intravaginal device |
| USD897530S1 (en) | 2019-04-23 | 2020-09-29 | Renovia Inc. | Intravaginal device |
| WO2021021588A1 (en) * | 2019-07-26 | 2021-02-04 | Photokinetix Holdings Inc. | Intravaginal devices, compositions and methods to treat atrophic vaginitis |
| WO2021071973A1 (en) * | 2019-10-07 | 2021-04-15 | Klang Gregg Alan | Light-based vaginal therapy devices and methods for use |
| USD922575S1 (en) | 2019-10-25 | 2021-06-15 | Renovia Inc. | Intravaginal device |
| KR102118510B1 (ko) * | 2020-03-16 | 2020-06-03 | 강선영 | Led, 고주파 및 ems를 이용한 질치료 장치 |
| WO2022183247A1 (en) * | 2021-03-04 | 2022-09-09 | Bradley Carden | A therapeutic massage device |
| US11957928B1 (en) | 2021-10-11 | 2024-04-16 | Flow State IP LLC | Friction-based therapeutic light penile device |
| KR20230175136A (ko) | 2022-06-21 | 2023-12-29 | 김혜빈 | 여성 골반저근육 강화기기, 이 기기와 연계된 사용자 단말 및 여성 골반저근육 관리 장치 |
Family Cites Families (52)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6218151U (zh) | 1985-07-18 | 1987-02-03 | ||
| US20020156402A1 (en) * | 1998-06-16 | 2002-10-24 | Philippe-Guy E. Woog | Sonic therapeutic machine for the body |
| IL126723A0 (en) | 1998-10-22 | 1999-08-17 | Medoc Ltd | Vaginal probe and method |
| US6454789B1 (en) | 1999-01-15 | 2002-09-24 | Light Science Corporation | Patient portable device for photodynamic therapy |
| GB0010686D0 (en) | 2000-05-03 | 2000-06-28 | Zinn Shiri | Stimulatory device |
| CN100482182C (zh) | 2002-06-19 | 2009-04-29 | 帕洛玛医疗技术公司 | 对一定深度的组织进行光热治疗的方法和装置 |
| AUPS313702A0 (en) | 2002-06-25 | 2002-07-18 | Riancorp Pty Ltd | Multi spot optics in medical applications |
| US20070015952A1 (en) * | 2003-09-26 | 2007-01-18 | Chang T D | Urinary frequency and urgency treatment device |
| EP1684866A1 (en) | 2003-11-14 | 2006-08-02 | Kim, Jin-il | Medical device for treating prostate diseases by using near-infrared led |
| US20060047281A1 (en) | 2004-09-01 | 2006-03-02 | Syneron Medical Ltd. | Method and system for invasive skin treatment |
| WO2006042163A2 (en) | 2004-10-06 | 2006-04-20 | Guided Therapy Systems, L.L.C. | Method and system for cosmetic enhancement |
| CA2491249A1 (en) | 2004-12-17 | 2006-06-17 | Bruce Murison | Electro-mechanical sexual stimulation device |
| US8109981B2 (en) * | 2005-01-25 | 2012-02-07 | Valam Corporation | Optical therapies and devices |
| WO2006103678A2 (en) | 2005-03-31 | 2006-10-05 | Esther Mayer | Probe device, system and method for photobiomodulation of tissue lining a body cavity |
| KR100710908B1 (ko) * | 2005-07-19 | 2007-04-27 | 김경일 | 요실금 검사치료 및 골반저근과 질근육의 바이오피드백 훈련용 장치 |
| USD574504S1 (en) | 2005-12-09 | 2008-08-05 | Jimmyjane, Inc. | Vibrating massager |
| USD613417S1 (en) | 2005-12-09 | 2010-04-06 | Jimmyjane, Inc. | Vibrating massager |
| WO2007092610A2 (en) | 2006-02-07 | 2007-08-16 | Tivamed, Inc. | Vaginal remodeling device and methods |
| CN2907735Y (zh) | 2006-03-21 | 2007-06-06 | 朱康年 | 一种妇科腔内理疗仪器 |
| US7527589B2 (en) * | 2006-04-10 | 2009-05-05 | John B Squicciarini | Therapeutic prosthetic device |
| JP2009542330A (ja) | 2006-06-27 | 2009-12-03 | パロマー・メデイカル・テクノロジーズ・インコーポレーテツド | 手持ち光美容装置 |
| US7850720B2 (en) * | 2006-09-23 | 2010-12-14 | Ron Shefi | Method and apparatus for applying light therapy |
| US7452326B2 (en) | 2006-10-13 | 2008-11-18 | British Columbia Institute Of British Columbia | User-friendly vibrostimulation device |
| CN101815493B (zh) | 2007-01-09 | 2013-07-03 | 吉米简有限公司 | 可再充电的个人按摩器 |
| CN101293124B (zh) * | 2007-04-29 | 2010-09-08 | 曾世一 | 一种阴部光照装置 |
| US20100049283A1 (en) | 2008-08-21 | 2010-02-25 | Bliss Holdings, Llc | Illumination-based medical device & methods of use thereof |
| US8357150B2 (en) | 2009-07-20 | 2013-01-22 | Syneron Medical Ltd. | Method and apparatus for fractional skin treatment |
| US8550983B2 (en) | 2009-01-06 | 2013-10-08 | Youngtack Shim | Dynamic control relaxing systems and methods |
| US8399731B2 (en) | 2009-03-19 | 2013-03-19 | Covidien Lp | Phototherapy wound treatment |
| CN101991915B (zh) * | 2009-08-14 | 2012-10-24 | 武汉亚格光电技术有限公司 | 半导体窄光谱妇科疾病治疗仪 |
| CN102711708A (zh) | 2009-08-26 | 2012-10-03 | 吉米简有限公司 | 具有柔性底层结构的按摩装置 |
| DK2477695T3 (en) | 2009-09-18 | 2016-01-25 | Viveve Inc | vaginal omformningsanordning |
| US20110190582A1 (en) | 2009-09-28 | 2011-08-04 | Bennett James D | Intravaginal optics targeting system |
| US8574177B2 (en) | 2010-03-11 | 2013-11-05 | Bwt Property, Inc. | Phototherapy and massage apparatus for treating medical conditions in body cavities |
| US8786689B1 (en) | 2010-04-15 | 2014-07-22 | Yongqian R. Liu | Modular optical medical diagnostic system |
| CA2805664C (en) * | 2010-07-23 | 2016-06-21 | Avacen, Inc. | Methods and apparatus for therapeutic application of thermal energy |
| US20120136287A1 (en) | 2010-11-29 | 2012-05-31 | Barnard Ellen L | Vaginal tissue regeneration device and method for regeneration of vaginal lining using vibration therapy |
| ES2440795T3 (es) | 2011-01-12 | 2014-01-30 | Fotona D.D. | Sistema láser para el tratamiento no ablativo de tejidos de la mucosa |
| CN201949064U (zh) * | 2011-02-18 | 2011-08-31 | 李彦 | 阴道拉钩 |
| AU2012235628B2 (en) | 2011-04-01 | 2015-07-16 | Syneron Beauty Ltd | A treatment device |
| KR101339402B1 (ko) | 2011-05-25 | 2013-12-09 | 주식회사 칼라세븐 | 색광 치료기 |
| JP6318088B2 (ja) * | 2011-07-26 | 2018-04-25 | アンフォラ メディカル， インコーポレイテッド | 骨盤神経組織を変調するための装置および方法 |
| US20130053630A1 (en) * | 2011-08-25 | 2013-02-28 | Shay WAIL | Smart capsule for providing sexual pleasure |
| CN102553084B (zh) * | 2012-03-02 | 2014-12-10 | 中山大学 | 一种光治疗装置 |
| US10413473B2 (en) | 2012-03-14 | 2019-09-17 | Ralph Zipper | Sexual stimulation device using light therapy, vibration and physiological feedback |
| WO2013138658A1 (en) | 2012-03-14 | 2013-09-19 | Zipper Ralph | Improved sexual stimulation device using light therapy and vibration |
| CN103301567B (zh) | 2012-03-16 | 2016-04-06 | 女康乐公司 | 一种修复女性阴道组织的治疗器 |
| US9717927B2 (en) | 2013-02-07 | 2017-08-01 | Rocomp Global, L.L.C. | Electromagnetic radiation targeting devices, assemblies, systems and methods |
| CN203169847U (zh) * | 2013-03-15 | 2013-09-04 | 武汉市九头鸟医疗仪器开发有限公司 | 一种宫颈炎治疗棒 |
| US9949889B2 (en) | 2013-11-11 | 2018-04-24 | Joylux, Inc. | At-home light-emitting diode and massage device for vaginal rejuvenation |
| WO2017049216A1 (en) | 2015-09-16 | 2017-03-23 | Viveve Medical, Inc. | Methods and systems for treating urinary stress incontinence |
| US10179085B2 (en) | 2015-10-02 | 2019-01-15 | Joylux, Inc. | Light-emitting diode and massage device for delivering focused light for vaginal rejuvenation |
-
2014
- 2014-11-10 US US14/537,869 patent/US9949889B2/en active Active
- 2014-11-11 WO PCT/US2014/065069 patent/WO2015070242A2/en active Application Filing
- 2014-11-11 CN CN201480072622.3A patent/CN105899180B/zh active Active
- 2014-11-11 CN CN201910638348.6A patent/CN110353965B/zh active Active
- 2014-11-11 KR KR1020167015571A patent/KR20160086374A/ko not_active Application Discontinuation
- 2014-11-11 AU AU2014346372A patent/AU2014346372A1/en not_active Abandoned
- 2014-11-11 CA CA2930252A patent/CA2930252C/en active Active
- 2014-11-11 EP EP14860017.4A patent/EP3068361B1/en active Active
- 2014-11-11 JP JP2016529993A patent/JP6772061B2/ja active Active
-
2016
- 2016-10-13 US US15/293,237 patent/US10166168B2/en active Active
-
2018
- 2018-10-10 US US16/157,047 patent/US10537491B2/en active Active
Cited By (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11090220B2 (en) | 2013-09-23 | 2021-08-17 | Novoluto Gbhh | Stimulation device |
| US11103418B2 (en) | 2013-09-23 | 2021-08-31 | Novoluto Gmbh | Stimulation device |
| US9949889B2 (en) | 2013-11-11 | 2018-04-24 | Joylux, Inc. | At-home light-emitting diode and massage device for vaginal rejuvenation |
| US10166168B2 (en) | 2013-11-11 | 2019-01-01 | Joylux, Inc. | At-home light-emitting diode and massage device for vaginal rejuvenation |
| US11833101B2 (en) | 2015-10-02 | 2023-12-05 | Joylux, Inc. | Light-emitting diode and massage device for delivering focused light for vaginal rejuvenation |
| US10179085B2 (en) | 2015-10-02 | 2019-01-15 | Joylux, Inc. | Light-emitting diode and massage device for delivering focused light for vaginal rejuvenation |
| US11116691B2 (en) | 2015-10-02 | 2021-09-14 | Joylux, Inc. | Light-emitting diode and massage device for delivering focused light for vaginal rejuvenation |
| WO2017058957A1 (en) * | 2015-10-02 | 2017-04-06 | Joylux, Inc. | A light-emitting diode and massage device for delivering focused light for vaginal rejuvenation |
| ITUB20155010A1 (it) * | 2015-11-02 | 2017-05-02 | Andrea Recchi | Dispositivo per il trattamento di tessuti umani |
| EP3405158B1 (de) | 2016-10-05 | 2019-12-25 | Novoluto GmbH | Verbesserte stimulationsvorrichtung |
| US11896823B2 (en) | 2017-04-04 | 2024-02-13 | Btl Healthcare Technologies A.S. | Method and device for pelvic floor tissue treatment |
| USD844804S1 (en) | 2017-05-12 | 2019-04-02 | Filip Sedic | Vaginal rejuvenation device |
| USD838862S1 (en) | 2017-05-12 | 2019-01-22 | Filip Sedic | Vaginal rejuvenation device |
| USD829922S1 (en) | 2017-05-12 | 2018-10-02 | Filip Sedic | Vaginal rejuvenation device |
| WO2022090787A1 (en) | 2020-11-02 | 2022-05-05 | Savantini Limited | An exercise system |
| DE202021104579U1 (de) | 2020-11-20 | 2022-02-23 | Medlight Gmbh | Liebeskugel |
| WO2022106082A1 (de) | 2020-11-20 | 2022-05-27 | Medlight Gmbh | Liebeskugel |
Also Published As
| Publication number | Publication date |
|---|---|
| CA2930252A1 (en) | 2015-05-14 |
| US20150133832A1 (en) | 2015-05-14 |
| EP3068361A4 (en) | 2017-08-23 |
| US10166168B2 (en) | 2019-01-01 |
| US20190038501A1 (en) | 2019-02-07 |
| CA2930252C (en) | 2021-03-02 |
| WO2015070242A3 (en) | 2015-10-29 |
| CN105899180B (zh) | 2019-07-26 |
| US20170028213A1 (en) | 2017-02-02 |
| EP3068361A2 (en) | 2016-09-21 |
| US9949889B2 (en) | 2018-04-24 |
| CN110353965A (zh) | 2019-10-22 |
| CN110353965B (zh) | 2022-05-06 |
| US10537491B2 (en) | 2020-01-21 |
| JP6772061B2 (ja) | 2020-10-21 |
| AU2014346372A1 (en) | 2016-06-02 |
| JP2016536073A (ja) | 2016-11-24 |
| CN105899180A (zh) | 2016-08-24 |
| KR20160086374A (ko) | 2016-07-19 |
| EP3068361B1 (en) | 2021-01-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10537491B2 (en) | At-home light-emitting diode and massage device for vaginal rejuvenation | |
| US11833101B2 (en) | Light-emitting diode and massage device for delivering focused light for vaginal rejuvenation | |
| US11253717B2 (en) | Aesthetic method of biological structure treatment by magnetic field | |
| US11266852B2 (en) | Aesthetic method of biological structure treatment by magnetic field | |
| US10471269B1 (en) | Aesthetic method of biological structure treatment by magnetic field | |
| US10478633B2 (en) | Aesthetic method of biological structure treatment by magnetic field | |
| US10569095B1 (en) | Aesthetic method of biological structure treatment by magnetic field | |
| US11691024B2 (en) | Aesthetic method of biological structure treatment by magnetic field | |
| US20200139148A1 (en) | Aesthetic method of biological structure treatment by magnetic field | |
| US20230117604A1 (en) | Aesthetic method of biological structure treatment by magnetic field | |
| EP3346937B1 (en) | Apparatus with handle assembly for radio frequency therapy | |
| CN209789999U (zh) | 痔疮水解治疗装置 | |
| KR101458083B1 (ko) | 파동을 이용한 치료장치 | |
| ITUB20155010A1 (it) | Dispositivo per il trattamento di tessuti umani |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 14860017 Country of ref document: EP Kind code of ref document: A2 |
|
| ENP | Entry into the national phase |
Ref document number: 2930252 Country of ref document: CA |
|
| ENP | Entry into the national phase |
Ref document number: 2016529993 Country of ref document: JP Kind code of ref document: A |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| REEP | Request for entry into the european phase |
Ref document number: 2014860017 Country of ref document: EP |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2014860017 Country of ref document: EP |
|
| ENP | Entry into the national phase |
Ref document number: 2014346372 Country of ref document: AU Date of ref document: 20141111 Kind code of ref document: A |
|
| ENP | Entry into the national phase |
Ref document number: 20167015571 Country of ref document: KR Kind code of ref document: A |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 14860017 Country of ref document: EP Kind code of ref document: A2 |